Racial differences in long-term adherence to oral antidiabetic drug therapy: A longitudinal cohort study

BMC Health Services Research

Volumn 9, Issue 1, 2009, Pages

  Trinacty, Connie M ^a   Adams, Alyce S ^a,b   Soumerai, Stephen B ^a   Zhang, Fang ^a   Meigs, James B ^c   Piette, John D ^d   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DIVISION OF RESEARCH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; RACE DIFFERENCE; AGED; LONGITUDINAL STUDY; MEDICAL AUDIT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RACE; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADULT; AGED; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES;

EID: 60849127894     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-24     Document Type: Article

References (31)

1. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008 31 596 615 10.2337/dc08-9017 18308683
2. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. MI Harris RC Eastman CC Cowie KM Flegal MS Eberhardt, Diabetes Care 1999 22 403 408 10.2337/diacare.22.3.403 10097918
3. Non-insulin-dependent diabetes mellitus in minorities in the United States. JS Carter JA Pugh A Monterrosa, Ann Intern Med 1996 125 221 232 8686981
4. Effects of intensive glucose lowering in type 2 diabetes. HC Gerstein ME Miller RP Byington DC Goff Jr JT Bigger JB Buse WC Cushman S Genuth F Ismail-Beigi RH Grimm Jr JL Probstfield DG Simons-Morton WT Friedewald, N Engl J Med 2008 358 2545 2559 10.1056/NEJMoa0802743 18539917
5. 10-year follow-up of intensive glucose control in type 2 diabetes. RR Holman SK Paul MA Bethel DR Matthews HA Neil, N Engl J Med 2008 359 1577 1589 10.1056/NEJMoa0806470 18784090
6. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. A Patel S MacMahon J Chalmers B Neal L Billot M Woodward M Marre M Cooper P Glasziou D Grobbee P Hamet S Harrap S Heller L Liu G Mancia CE Mogensen C Pan N Poulter A Rodgers B Williams S Bompoint BE de Galan R Joshi F Travert, N Engl J Med 2008 358 2560 2572 10.1056/NEJMicm066227 18539916
7. Effect of a multifactorial intervention on mortality in type 2 diabetes. P Gaede H Lund-Andersen HH Parving O Pedersen, N Engl J Med 2008 358 580 591 10.1056/NEJMoa0706245 18256393
8. Utilization of oral hypoglycemic agents in a drug-insured U.S. population. SJ Boccuzzi J Wogen J Fox JC Sung AB Shah J Kim, Diabetes Care 2001 24 1411 1415 10.2337/diacare.24.8.1411 11473078
9. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. PT Donnan TM MacDonald AD Morris, Diabet Med 2002 19 279 284 10.1046/j.1464-5491.2002.00689.x 11942998
10. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. BA Morningstar IS Sketris GC Kephart DA Sclar, J Clin Pharm Ther 2002 27 213 220 10.1046/j.1365-2710.2002.00411.x 12081636
11. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. C Melikian TJ White A Vanderplas CM Dezii E Chang, Clin Ther 2002 24 460 467 10.1016/S0149-2918(02)85047-0 11952029
12. Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes. Family and community contexts. WF Auslander S Thompson D Dreitzer NH White JV Santiago, Diabetes Care 1997 20 1569 1575 10.2337/diacare.20.10.1569 9314637
13. Ambulatory medical care for non-Hispanic whites, African-Americans, and Mexican-Americans with NIDDM in the U.S. CC Cowie MI Harris, Diabetes Care 1997 20 142 147 10.2337/diacare.20.2.142 9118761
14. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. M Heisler JD Faul RA Hayward KM Langa C Blaum D Weir, Arch Intern Med 2007 167 1853 1860 10.1001/archinte.167.17.1853 17893306
15. Personal-model beliefs and social-environmental barriers related to diabetes self-management. RE Glasgow SE Hampson LA Strycker L Ruggiero, Diabetes Care 1997 20 556 561 10.2337/diacare.20.4.556 9096980
16. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. AJ Karter A Ferrara JA Darbinian LM Ackerson JV Selby, Diabetes Care 2000 23 477 483 10.2337/diacare.23.4.477 10857938
17. Race differences in long-term diabetes management in an HMO. AS Adams F Zhang C Mah RW Grant K Kleinman JB Meigs D Ross-Degnan, Diabetes Care 2005 28 2844 2849 10.2337/diacare.28.12.2844 16306543
18. Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO. CM Trinacty AS Adams SB Soumerai F Zhang JB Meigs JD Piette D Ross-Degnan, J Gen Intern Med 2007 22 1506 1513 17763913 10.1007/s11606-007-0339-5
19. Racial differences in impact of coverage on diabetes self-monitoring in a health maintenance organization. CA Mah SB Soumerai AS Adams D Ross-Degnan, Med Care 2006 44 392 397 10.1097/01.mlr.0000207488.80213.74 16641656
20. Evaluation of a pharmaceutical care model on diabetes management. LA Jaber H Halapy M Fernet S Tummalapalli H Diwakaran, Ann Pharmacother 1996 30 238 243 8833557
21. Diabetes self-management. Self-reported recommendations and patterns in a large population. L Ruggiero R Glasgow JM Dryfoos JS Rossi JO Prochaska CT Orleans AV Prokhorov SR Rossi GW Greene GR Reed K Kelly L Chobanian S Johnson, Diabetes Care 1997 20 568 576 10.2337/diacare.20.4.568 9096982
22. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. PW Choo CS Rand TS Inui ML Lee E Cain M Cordeiro-Breault C Canning R Platt, Med Care 1999 37 846 857 10.1097/00005650-199909000-00002 10493464
23. HMO Research Network. KA Chan RL Davis MJ Gunter JH Gurwitz LJ Herrinton WW Nelson MA Raebel DW Roblin DH Smith R Platt, Pharmacoepidemiology 2005 261 270
24. The assessment of refill compliance using pharmacy records: methods, validity, and applications. JF Steiner AV Prochazka, J Clin Epidemiol 1997 50 9048695
25. Methods for evaluation of medication adherence and persistence using automated databases. SE Andrade KH Kahler F Frech KA Chan, Pharmacoepidemiol Drug Saf 2006 15 565 574 10.1002/pds.1230 16514590
26. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. S Schneeweiss JD Seeger M Maclure PS Wang J Avorn RJ Glynn, Am J Epidemiol 2001 154 854 864 10.1093/aje/154.9.854 11682368
27. SAS Institute Inc, SAS/STAT® User's Guide, Version 8 Cary, NC: SAS Institute 1999 http://support.sas.com/rnd/app/doc.html
28. PD Allison, Survival Analysis Using the SAS System: A Practical Guide Cary, NC: SAS Institute Inc 1995 http://support.sas.com/publishing/bbu/ companion-site/55233.html
29. Clarification of statements in 2003 clinical practice recommendations. V Rosival, Diabetes Care 2003 26 2484 10.2337/diacare.26.8.2484 12882898
30. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. JL Meier AL Swislocki JR Lopez RH Noth P Bartlebaugh D Siegel, Am J Manag Care 2002 8 557 565 12068962
31. The concept of race in Health Services Research: 1966 to 1990. DR Williams, Health Serv Res 1994 29 261 274 8063565